Skip to main content
HR 6400 118th Congress Health

To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.

Introduced: November 14, 2023 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
  We don't have the full action history for this bill yet. Check back soon.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6400: To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.. 118th Congress. Open America. https://openamerica.io/bill/118-HR-6400/
MLA
"H.R. 6400: To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-6400/.
Bluebook (legal)
H.R. 6400, 118th Cong. (2026), https://openamerica.io/bill/118-HR-6400/.
Markdown link
[H.R. 6400: To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.](https://openamerica.io/bill/118-HR-6400/)
Report a problem